Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
Lechner, K; Geissler, K; Jäger, U; Greinix, H; Kalhs, P.
Treatment of acute leukemia.
Ann Oncol. 1999; 10 Suppl 6(5):45-51
Doi: 10.1023/A:1008380202046
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Greinix Hildegard
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Leukemic cells are highly sensitive to chemotherapeutic agents. A reduction of the leukemic burden is easily achieved by chemotherapy in most cases. However, it is difficult to reduce the number of leukemic cells to such an extent that a regrowth does not occur and the patient is cured. Traditionally the therapy of acute leukemia is divided into induction and post remission therapy. The aim of the induction therapy is to reduce the number of leukemic cells to a morphologically undetectable level allowing normal hemopoiesis to recover. The goal of the post remission treatment is a further reduction of leukemic cells to zero or to very low levels which can be controlled by (still unknown) endogenous mechanisms. In some recent treatment protocols induction and the early part of post remission treatment are not strictly separated.
- Find related publications in this database (using NLM MeSH Indexing)
- Acute Disease -
- Antineoplastic Agents - administration & dosage Antineoplastic Agents - therapeutic use
- Antineoplastic Combined Chemotherapy Protocols - administration & dosage Antineoplastic Combined Chemotherapy Protocols - therapeutic use
- Bone Marrow Transplantation -
- Clinical Trials as Topic -
- Combined Modality Therapy -
- Humans -
- Leukemia, Myeloid - drug therapy Leukemia, Myeloid - therapy
- Neoadjuvant Therapy -
- Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy
- Remission Induction - methods